Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease

Andrea Gori, Maria Cristina Rossi, Giulia Marchetti, Daria Trabattoni, Chiara Molteni, Marta Cogliati, Alessandra Bandera, Mario Clerici, Fabio Franzetti

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1859-1861
Number of pages3
JournalAIDS (London, England)
Volume14
Issue number12
DOIs
Publication statusPublished - 2000

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Gori, A., Rossi, M. C., Marchetti, G., Trabattoni, D., Molteni, C., Cogliati, M., Bandera, A., Clerici, M., & Franzetti, F. (2000). Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease. AIDS (London, England), 14(12), 1859-1861. https://doi.org/10.1097/00002030-200008180-00026